Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Non-Current Assets (2016 - 2021)

Historic Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $1.0 billion.

  • Neurocrine Biosciences' Non-Current Assets rose 19262.37% to $1.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $3.3 billion, marking a year-over-year increase of 11072.11%. This contributed to the annual value of $718.5 million for FY2020, which is 5126.32% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Non-Current Assets stood at $1.0 billion, which was up 19262.37% from $846.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Non-Current Assets high stood at $1.0 billion for Q3 2021, and its period low was $49.9 million during Q1 2017.
  • Over the past 5 years, Neurocrine Biosciences' median Non-Current Assets value was $324.5 million (recorded in 2019), while the average stood at $406.3 million.
  • Per our database at Business Quant, Neurocrine Biosciences' Non-Current Assets tumbled by 1445.64% in 2017 and then soared by 48630.82% in 2018.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Non-Current Assets stood at $262.7 million in 2017, then dropped by 2.78% to $255.4 million in 2018, then soared by 86.0% to $475.0 million in 2019, then surged by 51.26% to $718.5 million in 2020, then skyrocketed by 40.79% to $1.0 billion in 2021.
  • Its Non-Current Assets stands at $1.0 billion for Q3 2021, versus $846.3 million for Q2 2021 and $761.0 million for Q1 2021.